63 related articles for article (PubMed ID: 448071)
1. Human transfer factors: structural properties suggested by HPRP chromatography and enzymatic sensitivities.
Burger DR; Vandenbark AA; Dunnick W; Kraybill W; Daves GD; Vetto RM
J Immunol; 1979 Mar; 122(3):1091-8. PubMed ID: 448071
[TBL] [Abstract][Full Text] [Related]
2. Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography.
Vandenbark AA; Burger DR; Dreyer DL; Daves GD; Vetto RM
J Immunol; 1977 Feb; 118(2):636-41. PubMed ID: 839073
[TBL] [Abstract][Full Text] [Related]
3. Properties of human transfer factor from KLH-immunized donors: dissociation of dermal transfer and proliferation augmenting activities.
Burger DR; Vandenbark AA; Dunnick W; Kraybill WG; Vetto RM
J Reticuloendothel Soc; 1978 Oct; 24(4):385-402. PubMed ID: 712720
[No Abstract] [Full Text] [Related]
4. Specificity and structural analysis of a guinea pig transfer factor-like activity.
Dunnick WA; Bach FH
J Immunol; 1977 Jun; 118(6):1944-50. PubMed ID: 68075
[TBL] [Abstract][Full Text] [Related]
5. Human transfer factor: fractionation and biologic activity.
Burger DR; Vandenbark AA; Daves D; Anderson WA; Vetto RM; Finke P
J Immunol; 1976 Sep; 117(3):789-96. PubMed ID: 134121
[TBL] [Abstract][Full Text] [Related]
6. Isolation and purification of HSV-1 specific transfer factor produced by HSV-1 immunized goat leukocyte dialysate.
Qi HY; Wan ZF; Su CZ
Acta Virol; 1992 May; 36(3):231-8. PubMed ID: 1360750
[TBL] [Abstract][Full Text] [Related]
7. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. II. Separation and partial characterization of the components in DLE producing antigen-dependent and antigen-independent effects.
Wilson GB; Fudenberg HH
J Lab Clin Med; 1979 May; 93(5):819-37. PubMed ID: 429877
[TBL] [Abstract][Full Text] [Related]
8. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
Wilson GB; Paddock GV; Fudenberg HH
Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
[TBL] [Abstract][Full Text] [Related]
9. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF.
Khan A; Thometz D; Garrison O; Hill JM
Ann Allergy; 1976 May; 36(5):330-6. PubMed ID: 1084716
[TBL] [Abstract][Full Text] [Related]
10. Bovine 'transfer factor': an oligoribonucleopeptide which initiates antigen-specific lymphocytes responsiveness.
Wilson GB; Paddock GV; Fudenberg HH
Thymus; 1982; 4(6):335-50. PubMed ID: 6191411
[TBL] [Abstract][Full Text] [Related]
11. Transfer factor--a lymphocyte cell surface component.
Schröder I; Lüneburg S
Allergol Immunopathol (Madr); 1984; 12(1):1-5. PubMed ID: 6731201
[TBL] [Abstract][Full Text] [Related]
12. [Transfer of delayed type hypersensitivity in guinea pigs].
Smogorzewska E
Probl Med Wieku Rozwoj; 1990; 16():167-88. PubMed ID: 2152405
[TBL] [Abstract][Full Text] [Related]
13. Human transfer factor: effects on lymphocyte transformation.
Burger DR; Vandenbark AA; Finke P; Nolte JE; Vetto RM
J Immunol; 1976 Sep; 117(3):782-8. PubMed ID: 956653
[TBL] [Abstract][Full Text] [Related]
14. A structural model for human transfer factor.
Burger DR; Wampler PA; Vandenbark AA; Regan DH
Ann N Y Acad Sci; 1979; 332():236-40. PubMed ID: 231401
[No Abstract] [Full Text] [Related]
15. In vitro determination of effects of dialyzable leukocyte extracts containing transfer factor activity.
Schroder I; Rovensky J
Allergol Immunopathol (Madr); 1982; 10(3):171-6. PubMed ID: 7148610
[TBL] [Abstract][Full Text] [Related]
16. [The preparation and characterization of transfer factor (author's transl)].
Schröder I; Werner H; Lorenz U; Köhler H; Jenssen HL
Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):365-71. PubMed ID: 126568
[TBL] [Abstract][Full Text] [Related]
17. Fractionation studies on human leucocyte dialyzates. Demonstration of three components with transfer factor activity.
Krohn K; Gröhn P; Horsmanheimo M; Virolainen M
Med Biol; 1976 Dec; 54(5):334-40. PubMed ID: 994567
[TBL] [Abstract][Full Text] [Related]
18. Concentration of murine antigen-specific transfer factor of defined potency.
Mayer V; Valásková M; Gajdosová E; Oravec C
Acta Virol; 1983 May; 27(3):228-37. PubMed ID: 6138984
[TBL] [Abstract][Full Text] [Related]
19. Transfer factor therapy of thoracic sarcoidosis.
Vezendi S; Schröder I
Allergol Immunopathol (Madr); 1989; 17(1):35-7. PubMed ID: 2750639
[TBL] [Abstract][Full Text] [Related]
20. Transfer factor: hypoxanthine is a major component of a fraction with in vivo activity.
Tomar RH; Knight R; Stern M
J Allergy Clin Immunol; 1976 Jul; 58(1 PT. 2):190-7. PubMed ID: 956555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
